Association between dyslipidemia and plasma levels of branched-chain amino acids in the Japanese population without diabetes mellitus

Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2889, 10.1016/j.jacc.2013.11.002 Rana, 2010, Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study, Int J Cardiol, 143, 399, 10.1016/j.ijcard.2009.03.123 2002, Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143 Rana, 2015, Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl., Am J Cardiol, 116, 1700, 10.1016/j.amjcard.2015.08.039 Mook-Kanamori, 2014, Increased amino acids levels and the risk of developing of hypertriglyceridemia in a 7-year follow-up, J Endocrinol Invest, 37, 369, 10.1007/s40618-013-0044-7 Yamakado, 2015, Plasma free amino acid profiles predict four-year risk of developing diabetes, metabolic syndrome, dyslipidemia, and hypertension in Japanese population, Sci Rep, 5, 11918, 10.1038/srep11918 Yang, 2016, The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population, Lipids Health Dis, 15, 120, 10.1186/s12944-016-0291-7 Halama, 2016, Metabolic switch during adipogenesis: from branched chain amino acid catabolism to lipid synthesis, Arch Biochem Biophys, 589, 93, 10.1016/j.abb.2015.09.013 Yang, 2014, Association of branched-chain amino acids with carotid intima-media thickness and coronary artery disease risk factors, PLoS One, 9, e99598, 10.1371/journal.pone.0099598 Harada, 2016, Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men, Environ Health Prev Med, 21, 18, 10.1007/s12199-015-0494-y Harada, 2018, Reliability of plasma polar metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry, PLoS One, 13, e0191230, 10.1371/journal.pone.0191230 Seino, 2010, Report of the committee on the classification and diagnostic criteria of diabetes mellitus, J Diabetes Investig, 1, 212, 10.1111/j.2040-1124.2010.00074.x Horio, 2010, Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates, Am J Kidney Dis, 56, 32, 10.1053/j.ajkd.2010.02.344 Chen, 2016, Prevalence of abnormal serum liver enzymes in patients with type 2 diabetes mellitus: a cross-sectional study from China, Postgrad Med, 128, 770, 10.1080/00325481.2016.1242366 Fukai, 2016, Metabolic profiling of total physical activity and sedentary behavior in community-dwelling men, PLoS One, 11, e0164877, 10.1371/journal.pone.0164877 Iida, 2016, Profiling of plasma metabolites in postmenopausal women with metabolic syndrome, Menopause, 23, 749, 10.1097/GME.0000000000000630 Wakabayashi, 2018, Associations between sleep-disordered breathing and metabolic risk factors beyond obesity, J Diabetes Res, 2018, 1567683, 10.1155/2018/1567683 Kuwabara, 2016, Relationship between non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in the general population, J Atheroscler Thromb, 23, 477, 10.5551/jat.33100 Cui, 2001, Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality, Arch Intern Med, 161, 1413, 10.1001/archinte.161.11.1413 Kinoshita, 2018, Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017, J Atheroscler Thromb, 25, 846, 10.5551/jat.GL2017 Newgard, 2012, Interplay between lipids and branched-chain amino acids in development of insulin resistance, Cell Metab, 15, 606, 10.1016/j.cmet.2012.01.024 Wang, 2011, Metabolite profiles and the risk of developing diabetes, Nat Med, 17, 448, 10.1038/nm.2307 McCormack, 2013, Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents, Pediatr Obes, 8, 52, 10.1111/j.2047-6310.2012.00087.x Lin, 2018, Associations of lipid parameters with insulin resistance and diabetes: a population-based study, Clin Nutr, 37, 1423, 10.1016/j.clnu.2017.06.018 Cheng, 2018, Dose-response association between the triglycerides: high-density lipoprotein cholesterol ratio and type 2 diabetes mellitus risk: the rural Chinese cohort study and meta-analysis, J Diabetes, 11, 183, 10.1111/1753-0407.12836 She, 2007, Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism, Am J Physiol Endocrinol Metab, 293, E1552, 10.1152/ajpendo.00134.2007 Newgard, 2009, A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance, Cell Metab, 9, 311, 10.1016/j.cmet.2009.02.002 Huffman, 2009, Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women, Diabetes Care, 32, 1678, 10.2337/dc08-2075 Shimobayashi, 2016, Multiple amino acid sensing inputs to mTORC1, Cell Res, 26, 7, 10.1038/cr.2015.146 Bakan, 2012, Connecting mTORC1 signaling to SREBP-1 activation, Curr Opin Lipidol, 23, 226, 10.1097/MOL.0b013e328352dd03 Han, 2018, mTORC1 signaling in hepatic lipid metabolism, Protein Cell, 9, 145, 10.1007/s13238-017-0409-3 Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J Clin Invest, 109, 1125, 10.1172/JCI0215593 Laplante, 2009, mTOR signaling at a glance, J Cell Sci, 122, 3589, 10.1242/jcs.051011